{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T21:11:38Z","timestamp":1768770698457,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Boehringer Ingelheim Vetmedica GmbH"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.vaccine.2016.05.042","type":"journal-article","created":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T21:31:06Z","timestamp":1465421466000},"page":"3862-3866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Assessment of safety and reproductive performance after vaccination with a modified live-virus PRRS genotype 1 vaccine in pregnant sows at various stages of gestation"],"prefix":"10.1016","volume":"34","author":[{"given":"Julia","family":"Stadler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Zoels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Eddicks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Ritzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ladinig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.05.042_b0005","first-page":"629","article-title":"Nidovirales: a new order comprising Coronaviridae and Arteriviridae","volume":"142","author":"Cavanagh","year":"1997","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2016.05.042_b0010","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/BF01322671","article-title":"Comparison of the structural protein coding sequences of the VR-2332 and Lelystad virus strains of the PRRS virus","volume":"140","author":"Murtaugh","year":"1995","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2016.05.042_b0015","first-page":"72","article-title":"Assessment of the economic impact of porcine reproductive and respiratory syndrome virus on United States pork producers","volume":"21","author":"Holtkamp","year":"2013","journal-title":"J Swine Health Prod"},{"key":"10.1016\/j.vaccine.2016.05.042_b0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2460\/javma.2005.227.385","article-title":"Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States","volume":"227","author":"Neumann","year":"2005","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2016.05.042_b0025","first-page":"22","article-title":"An evaluation of test and removal for the elimination of porcine reproductive and respiratory syndrome virus from 5 swine farms","volume":"65","author":"Dee","year":"2001","journal-title":"Can J Veter Res = Rev Can de Rech Vet"},{"key":"10.1016\/j.vaccine.2016.05.042_b0030","series-title":"Eradication using herd closure","first-page":"157","author":"Torremorell","year":"2003"},{"key":"10.1016\/j.vaccine.2016.05.042_b0035","first-page":"416727","article-title":"Comparison of host immune responses to homologous and heterologous type II porcine reproductive and respiratory syndrome virus (PRRSV) challenge in vaccinated and unvaccinated pigs","volume":"2014","author":"Li","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.vaccine.2016.05.042_b0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.vetimm.2005.07.026","article-title":"Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus","volume":"109","author":"Charerntantanakul","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2016.05.042_b0045","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/088282402320914485","article-title":"Immunological responses of swine to porcine reproductive and respiratory syndrome virus infection","volume":"15","author":"Murtaugh","year":"2002","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2016.05.042_b0050","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1016\/j.vaccine.2004.05.008","article-title":"Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy","volume":"22","author":"Labarque","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.05.042_b0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.virol.2006.03.046","article-title":"Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs","volume":"351","author":"Diaz","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.05.042_b0060","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1016\/j.vaccine.2007.03.031","article-title":"Impact of a modified-live porcine reproductive and respiratory syndrome virus vaccine intervention on a population of pigs infected with a heterologous isolate","volume":"25","author":"Cano","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.05.042_b0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.vetmic.2007.02.009","article-title":"Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge","volume":"123","author":"Zuckermann","year":"2007","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2016.05.042_b0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0378-1135(97)00159-4","article-title":"Duration of homologous porcine reproductive and respiratory syndrome virus immunity in pregnant swine","volume":"58","author":"Lager","year":"1997","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2016.05.042_b0075","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.vaccine.2011.10.075","article-title":"Effect of modified-live porcine reproductive and respiratory syndrome virus (PRRSv) vaccine on the shedding of wild-type virus from an infected population of growing pigs","volume":"30","author":"Linhares","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.05.042_b0080","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tvjl.2005.07.015","article-title":"Effects of two commercial European modified-live vaccines against porcine reproductive and respiratory syndrome viruses in pregnant gilts","volume":"172","author":"Scortti","year":"2006","journal-title":"Veter J"},{"key":"10.1016\/j.vaccine.2016.05.042_b0085","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.theriogenology.2006.04.043","article-title":"Reproductive performance of gilts following vaccination and subsequent heterologous challenge with European strains of porcine reproductive and respiratory syndrome virus","volume":"66","author":"Scortti","year":"2006","journal-title":"Theriogenology"},{"key":"10.1016\/j.vaccine.2016.05.042_b0090","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1016\/S0264-410X(01)00099-8","article-title":"A quantitative assessment of the effectiveness of PRRSV vaccination in pigs under experimental conditions","volume":"19","author":"Nodelijk","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.05.042_b0095","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1016\/j.vaccine.2009.04.022","article-title":"Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology","volume":"27","author":"Kimman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.05.042_b0100","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/vr.141.19.497","article-title":"Appearance of acute PRRS-like symptoms in sow herds after vaccination with a modified live PRRS vaccine","volume":"141","author":"Botner","year":"1997","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2016.05.042_b0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/104063879200400202","article-title":"Characterization of swine infertility and respiratory syndrome (SIRS) virus (isolate ATCC VR-2332)","volume":"4","author":"Benfield","year":"1992","journal-title":"J Veter Diagn Invest"},{"key":"10.1016\/j.vaccine.2016.05.042_b0110","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2460\/ajvr.1996.57.06.834","article-title":"Comparison among strains of porcine reproductive and respiratory syndrome virus for their ability to cause reproductive failure","volume":"57","author":"Mengeling","year":"1996","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2016.05.042_b0115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/vr.158.14.475","article-title":"Randomised, placebo-controlled trial of a live vaccine against porcine reproductive and respiratory syndrome virus in sows on infected farms","volume":"158","author":"Pejsak","year":"2006","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2016.05.042_b0120","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/vr.161.24.809","article-title":"Failure of an inactivated vaccine against porcine reproductive and respiratory syndrome to protect gilts against a heterologous challenge with PRRSV","volume":"161","author":"Scortti","year":"2007","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2016.05.042_b0125","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1016\/j.vaccine.2009.03.028","article-title":"Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: clinical protection and cell-mediated immunity","volume":"27","author":"Martelli","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.05.042_b0130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.vetmic.2005.10.007","article-title":"Sow performance in an endemically porcine reproductive and respiratory syndrome (PRRS)-infected farm after sow vaccination with an attenuated PRRS vaccine","volume":"111","author":"Alexopoulos","year":"2005","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2016.05.042_b0135","doi-asserted-by":"crossref","first-page":"8192","DOI":"10.1016\/j.vaccine.2011.09.013","article-title":"Immunological solutions for treatment and prevention of porcine reproductive and respiratory syndrome (PRRS)","volume":"29","author":"Murtaugh","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.05.042_b0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0378-1135(03)00157-3","article-title":"Respiratory tract protection upon challenge of pigs vaccinated with attenuated porcine reproductive and respiratory syndrome virus vaccines","volume":"95","author":"Labarque","year":"2003","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2016.05.042_b0145","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0378-1135(00)00196-6","article-title":"Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development","volume":"74","author":"Meng","year":"2000","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2016.05.042_b0150","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1292\/jvms.70.1017","article-title":"Efficacy of vaccination with porcine reproductive and respiratory syndrome virus following challenges with field isolates in Japan","volume":"70","author":"Okuda","year":"2008","journal-title":"J Veter Med Sci\/Jpn Soc Veter Sci"},{"key":"10.1016\/j.vaccine.2016.05.042_b0155","first-page":"176","article-title":"PRRSV: comparison of commercial vaccines in their stability to induce protection against current PRRSV strains of high virulence","volume":"vol. 25","author":"Osorio","year":"1998"},{"key":"10.1016\/j.vaccine.2016.05.042_b0160","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.tvjl.2007.01.021","article-title":"Similarity of European porcine reproductive and respiratory syndrome virus strains to vaccine strain is not necessarily predictive of the degree of protective immunity conferred","volume":"175","author":"Prieto","year":"2008","journal-title":"Veter J"},{"key":"10.1016\/j.vaccine.2016.05.042_b0165","first-page":"246","article-title":"Genomic homology of ORF 5 gene sequence between modified live vaccine virus and porcine reproductive and respiratory syndrome virus challenge isolates is not predictive of vaccine efficacy","volume":"13","author":"Opriessnig","year":"2005","journal-title":"J Swine Health Prod"},{"key":"10.1016\/j.vaccine.2016.05.042_b0170","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0195-5616(01)50604-X","article-title":"Vaccine-associated adverse events","volume":"31","author":"Meyer","year":"2001","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.vaccine.2016.05.042_b0175","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1016\/S0264-410X(00)00498-9","article-title":"Adjuvants designed for veterinary and human vaccines","volume":"19","author":"Aucouturier","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.05.042_b0180","first-page":"348","article-title":"The tissue compatibility of different Mycoplasma hyopneumoniae vaccines is mainly dependent upon their adjuvants","volume":"122","author":"Elicker","year":"2009","journal-title":"Berl Munch Tierarztl Wochenschr"},{"key":"10.1016\/j.vaccine.2016.05.042_b0185","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.provac.2012.04.018","article-title":"Load reduction in live PRRS vaccines using oil and polymer adjuvants","volume":"6","author":"Deville","year":"2012","journal-title":"Proc Vaccinol"},{"key":"10.1016\/j.vaccine.2016.05.042_b0190","first-page":"300","article-title":"Carbomers and their use in pharmaceutical technology","volume":"53","author":"Rabiskova","year":"2004","journal-title":"Ceska a Slovenska farmacie: casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti"},{"key":"10.1016\/j.vaccine.2016.05.042_b0195","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF03226414","article-title":"Biopharmaceutical characterization of sustained release matrix tablets based on novel carbomer polymers: formulation and in vivo investigation","volume":"30","author":"Jelena","year":"2005","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.vaccine.2016.05.042_b0200","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1081\/DDC-100101318","article-title":"Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: a review","volume":"26","author":"Singla","year":"2000","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.vaccine.2016.05.042_b0205","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S0950268800057848","article-title":"Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant","volume":"112","author":"Mumford","year":"1994","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.05.042_b0210","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.vetmic.2015.02.001","article-title":"Carbopol improves the early cellular immune responses induced by the modified-life vaccine Ingelvac PRRS\u00ae MLV","volume":"176","author":"Mair","year":"2015","journal-title":"Vet Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16303681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16303681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T12:35:45Z","timestamp":1718627745000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16303681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":42,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0264410X16303681"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.05.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of safety and reproductive performance after vaccination with a modified live-virus PRRS genotype 1 vaccine in pregnant sows at various stages of gestation","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.vaccine.2016.05.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}